BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29170133)

  • 1. Downregulation of Bit1 expression promotes growth, anoikis resistance, and transformation of immortalized human bronchial epithelial cells via Erk activation-dependent suppression of E-cadherin.
    Yao X; Gray S; Pham T; Delgardo M; Nguyen A; Do S; Ireland SK; Chen R; Abdel-Mageed AB; Biliran H
    Biochem Biophys Res Commun; 2018 Jan; 495(1):1240-1248. PubMed ID: 29170133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Anoikis Effector Bit1 Inhibits EMT through Attenuation of TLE1-Mediated Repression of E-Cadherin in Lung Cancer Cells.
    Yao X; Pham T; Temple B; Gray S; Cannon C; Chen R; Abdel-Mageed AB; Biliran H
    PLoS One; 2016; 11(9):e0163228. PubMed ID: 27655370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLE1 promotes EMT in A549 lung cancer cells through suppression of E-cadherin.
    Yao X; Ireland SK; Pham T; Temple B; Chen R; Raj MH; Biliran H
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):277-84. PubMed ID: 25446087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anoikis effector Bit1 displays tumor suppressive function in lung cancer cells.
    Yao X; Jennings S; Ireland SK; Pham T; Temple B; Davis M; Chen R; Davenport I; Biliran H
    PLoS One; 2014; 9(7):e101564. PubMed ID: 25003198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLE1 is an anoikis regulator and is downregulated by Bit1 in breast cancer cells.
    Brunquell C; Biliran H; Jennings S; Ireland SK; Chen R; Ruoslahti E
    Mol Cancer Res; 2012 Nov; 10(11):1482-95. PubMed ID: 22952044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLE1 inhibits anoikis and promotes tumorigenicity in human lung cancer cells through ZEB1-mediated E-cadherin repression.
    Yao X; Pham T; Temple B; Gray S; Cannon C; Hardy C; Fletcher K; Ireland SK; Hossain A; Chen R; Abdel-Mageed AB; Biliran H
    Oncotarget; 2017 Sep; 8(42):72235-72249. PubMed ID: 29069783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastasis of tumor cells is enhanced by downregulation of Bit1.
    Karmali PP; Brunquell C; Tram H; Ireland SK; Ruoslahti E; Biliran H
    PLoS One; 2011; 6(8):e23840. PubMed ID: 21886829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bit1 in anoikis resistance and tumor metastasis.
    Jenning S; Pham T; Ireland SK; Ruoslahti E; Biliran H
    Cancer Lett; 2013 Jun; 333(2):147-51. PubMed ID: 23376255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anoikis effector Bit1 negatively regulates Erk activity.
    Kairouz-Wahbe R; Biliran H; Luo X; Khor I; Wankell M; Besch-Williford C; Pascual J; Oshima R; Ruoslahti E
    Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1528-32. PubMed ID: 18218778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase D is a positive regulator of Bit1 apoptotic function.
    Biliran H; Jan Y; Chen R; Pasquale EB; Ruoslahti E
    J Biol Chem; 2008 Oct; 283(42):28029-37. PubMed ID: 18703509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bit1 knockdown contributes to growth suppression as well as the decreases of migration and invasion abilities in esophageal squamous cell carcinoma via suppressing FAK-paxillin pathway.
    Fan T; Chen J; Zhang L; Gao P; Hui Y; Xu P; Zhang X; Liu H
    Mol Cancer; 2016 Mar; 15():23. PubMed ID: 26956728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term exposures to low doses of silver nanoparticles enhanced in vitro malignant cell transformation in non-tumorigenic BEAS-2B cells.
    Choo WH; Park CH; Jung SE; Moon B; Ahn H; Ryu JS; Kim KS; Lee YH; Yu IJ; Oh SM
    Toxicol In Vitro; 2016 Dec; 37():41-49. PubMed ID: 27596524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. βA3/A1-Crystallin controls anoikis-mediated cell death in astrocytes by modulating PI3K/AKT/mTOR and ERK survival pathways through the PKD/Bit1-signaling axis.
    Ma B; Sen T; Asnaghi L; Valapala M; Yang F; Hose S; McLeod DS; Lu Y; Eberhart C; Zigler JS; Sinha D
    Cell Death Dis; 2011 Oct; 2(10):e217. PubMed ID: 21993393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bit1 mediates the malignant behaviors in pancreatic cancer and its potential clinical significance].
    Huang S; Yuan D; Guo JC; Zhang TP; Zhao YP
    Zhonghua Wai Ke Za Zhi; 2017 Nov; 55(11):857-862. PubMed ID: 29136735
    [No Abstract]   [Full Text] [Related]  

  • 15. TDAG51 is an ERK signaling target that opposes ERK-mediated HME16C mammary epithelial cell transformation.
    Oberst MD; Beberman SJ; Zhao L; Yin JJ; Ward Y; Kelly K
    BMC Cancer; 2008 Jul; 8():189. PubMed ID: 18597688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic ras-induced down-regulation of pro-apoptotic protease caspase-2 is required for malignant transformation of intestinal epithelial cells.
    Yoo BH; Wang Y; Erdogan M; Sasazuki T; Shirasawa S; Corcos L; Sabapathy K; Rosen KV
    J Biol Chem; 2011 Nov; 286(45):38894-903. PubMed ID: 21903589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HAb18G/CD147 cell-cell contacts confer resistance of a HEK293 subpopulation to anoikis in an E-cadherin-dependent manner.
    Ma XK; Wang L; Li Y; Yang XM; Zhao P; HaoTang ; Zhu P; Li L; Chen ZN
    BMC Cell Biol; 2010 Apr; 11():27. PubMed ID: 20398401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detachment-induced E-cadherin expression promotes 3D tumor spheroid formation but inhibits tumor formation and metastasis of lung cancer cells.
    Powan P; Luanpitpong S; He X; Rojanasakul Y; Chanvorachote P
    Am J Physiol Cell Physiol; 2017 Nov; 313(5):C556-C566. PubMed ID: 28931539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen decreases anoikis of ovarian cancer cell line Caov-3 through reducing release of Bit1.
    Zheng J; Zhou J; Xie X; Xie B; Lin J; Xu Z; Zhang W
    DNA Cell Biol; 2014 Dec; 33(12):847-53. PubMed ID: 25211327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bit1-a potential positive regulator of epithelial-mesenchymal transition in lens epithelial cells.
    Wu X; Ruan J; Ma B; Luo M
    Graefes Arch Clin Exp Ophthalmol; 2016 Jul; 254(7):1311-8. PubMed ID: 27122244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.